The Cell Therapy Area at 3P is working on various projects for regenerative medicine in two different consortia, involving prestigious universities, hospitals and a number of specialized SME’s. These projects are focused on addressing diseases that currently have no medical solution, and that may, in the near future, be available on the market.

In one such project led by 3P, researchers are developing a tissue engineering product, indicated for autologous treatment of vitiligo. The original product has been tested in a clinical trial, in Clinica Universidad de Navarra, showing very satisfactory results.

Several projects are being carried out for the production of intermediates products (growing media and biomaterials), one of them in collaboration with groups from the Center for Biomedical Research/Network in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN).

Likewise, this area is developing, in other participative project, an industrial process for allogeneic cell therapy to restore cardiac diseases using adult stem cells.